Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fgjml9/neurostimulation) has announced the addition of the "Neurostimulation - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES).
The United States is analyzed both in terms of value (US$) and volume (units) sales.
The report profiles 30 companies including many key and niche players such as
- Aleva Neurotherapeutics SA (Switzerland)
- BioControl Medical (Israel)
- Bioness Inc. (USA)
- Boston Scientific Corp. (USA)
- EnteroMedics Inc. (USA)
- LivaNova PLC (UK)
- Medtronic, Inc. (USA)
- NeuroPace, Inc. (USA)
- NeuroSigma, Inc. (USA)
- Nevro Corp. (USA)
- SPR Therapeutics, LLC (US)
- St. Jude Medical, Inc. (USA)
- Synapse Biomedical, Inc. (USA)
Key Topics Covered:
1. MARKET OVERVIEW
2. COMPETITIVE SCENARIO
3. GROWTH DRIVERS, TRENDS, & ISSUES
4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY
5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET
6. SELECT TARGETED INDICATIONS
7. PRODUCT OVERVIEW
8. NEUROSTIMULATION DEVICE APPROVALS
9. PRODUCT INNOVATIONS/INTRODUCTIONS
10. RECENT INDUSTRY ACTIVITY
11. FOCUS ON SELECT PLAYERS
12. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)
- The United States (23)
- Europe (7)
- - Germany (2)
- - The United Kingdom (2)
- - Rest of Europe (3)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/fgjml9/neurostimulation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Neurology Devices


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



